{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:38:48Z","timestamp":1788475128603,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It is uncertain whether a liberal red blood cell (RBC) transfusion strategy is superior to a restrictive approach in patients with acute coronary syndrome (ACS) and anemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov from inception to April 2024 for randomized controlled trials (RCTs) comparing liberal and restrictive transfusion strategies in ACS patients with concurrent anemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five RCTs (4,510 patients) were included in this meta-analysis. There was no significant difference between the liberal and restrictive RBC transfusion strategy groups in the risk of major adverse cardiovascular events (MACE) (RR 0.91, 95% CI: 0.68\u20131.21; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200963%) and all-cause mortality (RR 0.85, 95% CI: 0.72, 1.00; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%). A liberal transfusion strategy reduced the risk of myocardial infarction (MI) (RR 0.80, 95% CI: 0.66, 0.98; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%). There were no significant differences between the two strategies in the risk of revascularization, heart failure, stroke, cardiac mortality, acute kidney injury or failure, and pneumonia, bacteremia, or infection. Liberal transfusion increased the risk of acute lung injury (RR 8.97, 95% CI: 1.65, 48.65; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our meta-analysis demonstrated that a liberal RBC transfusion strategy reduced the risk of MI and increased the risk of acute lung injury but did not affect other clinical outcomes compared to a restrictive approach in patients with mainly acute MI and anemia. New large-scale multicenter RCTs are required to confirm or refute our findings and provide more reliable results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p>PROSPERO (CRD42024506844).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1457400","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T14:12:07Z","timestamp":1745503927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Liberal versus restrictive red blood cell transfusion strategy in acute coronary syndrome and anemia: an updated systematic review and meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Sinda","family":"Hidri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeh","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Gardezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassim Zaheen","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Venkata Siddhartha","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiela E.","family":"Almansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arslan","family":"Maan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirth","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeja","family":"Catic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranjeet Singh","family":"Nagoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ebad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaifa Ahmad","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid Ben","family":"Selma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhamed Amr","family":"Sabouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Braiteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Yarkoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyoor","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e003348","DOI":"10.1161\/JAHA.116.003348","article-title":"Relationship between anemia and mortality outcomes in a national acute coronary syndrome cohort: insights from the UK myocardial ischemia national audit project registry","volume":"5","author":"Mamas","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/clc.23219","article-title":"Outcomes of anemic patients presenting with acute coronary syndrome: an analysis of the cooperative national registry of acute coronary care, guideline adherence and clinical events","volume":"42","author":"Huynh","year":"2019","journal-title":"Clin Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/01.cir.0000162477.70955.5f","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/VHRM.S140951","article-title":"Anemia and acute coronary syndrome: current perspectives","volume":"14","author":"Stucchi","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"B5","article-title":"Blood transfusion","volume-title":"StatPearls","author":"Lotterman","year":"2024"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrcardio.2013.14","article-title":"Acute coronary syndromes: blood transfusion in patients with acute MI and anaemia","volume":"10","author":"Sherwood","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.55729\/2000-9666.1051","article-title":"Restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction: a meta-analysis of randomized clinical trials","volume":"12","author":"Abdelazeem","year":"2022","journal-title":"J. Community Hosp Intern Med Perspect"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","article-title":"Restrictive or liberal transfusion strategy in myocardial infarction and anemia","volume":"389","author":"Carson","year":"2023","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"B13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ahj.2013.03.001","article-title":"Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease","volume":"165","author":"Carson","year":"2013","journal-title":"Am Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.amjcard.2011.06.014","article-title":"Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study)","volume":"108","author":"Cooper","year":"2011","journal-title":"Am J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jama.2021.0135","article-title":"Effect of a restrictive vs liberal blood transfusion strategy on Major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial","volume":"325","author":"Ducrocq","year":"2021","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCULATIONAHA.121.057909","article-title":"One-year major cardiovascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial","volume":"145","author":"Gonzalez-Juanatey","year":"2022","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e028497","DOI":"10.1161\/JAHA.122.028497","article-title":"Transfusion thresholds for acute coronary syndromes-insights from the TRICS-III randomized controlled trial, systematic review, and meta-analysis","volume":"12","author":"Mistry","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jcin.2024.01.085","article-title":"100.19 restrictive versus liberal blood transfusion in patients with myocardial infarction and Anemia: a meta-analysis of randomized clinical trials","volume":"17","author":"Goel","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.hsr.2022.100059","article-title":"Restrictive versus liberal transfusion for anemic patients with acute myocardial infarction: systematic review and meta-analysis","volume":"5","author":"Kou","year":"2022","journal-title":"Health Sci Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102247","DOI":"10.1016\/j.cpcardiol.2023.102247","article-title":"Liberal versus conservative transfusion strategy for patients with acute myocardial infarction and anemia: a systematic review and meta-analysis","volume":"49","author":"Sukhon","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/03007995.2017.1280010","article-title":"Restrictive versus liberal blood transfusion in patients with coronary artery disease: a meta-analysis","volume":"33","author":"Wang","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"B25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MCA.0b013e328359614c","article-title":"Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction","volume":"23","author":"Ergelen","year":"2012","journal-title":"Coron Artery Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jacc.2013.11.029","article-title":"Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry)","volume":"63","author":"Silvain","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/2013.jamainternmed.1001","article-title":"Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis","volume":"173","author":"Chatterjee","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"CD002042","DOI":"10.1002\/14651858.CD002042.pub5","article-title":"Transfusion thresholds for guiding red blood cell transfusion","volume":"12","author":"Carson","year":"2021","journal-title":"Cochrane Database Syst. Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage","volume":"316","author":"Carson","year":"2016","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2450\/BloodTransfus.427","article-title":"Acute myocardial infarction and blood transfusion: lessons learned from animal models and clinical studies","volume":"21","author":"Roubinian","year":"2023","journal-title":"Blood Transfus"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e009026","DOI":"10.1161\/CIRCINTERVENTIONS.120.009026","article-title":"Early adverse impact of transfusion after transcatheter aortic valve replacement","volume":"13","author":"Zimarino","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/trf.16449","article-title":"Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 national blood collection and utilization survey","volume":"61","author":"Jones","year":"2021","journal-title":"Transfusion"},{"key":"B33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/ehjqcco\/qcac029","article-title":"Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses","volume":"9","author":"Durand-Zaleski","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1457400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T14:12:09Z","timestamp":1745503929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1457400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2025.1457400"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1457400","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1457400"}}